AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
19.55
-0.03 (-0.15%)
May 9, 2025, 1:02 PM - Market open
AnaptysBio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 37.75, with a low estimate of 20 and a high estimate of 54. The average target predicts an increase of 93.09% from the current stock price of 19.55.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 5 | 5 | 6 | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $52 → $54 | Strong Buy | Maintains | $52 → $54 | +176.21% | May 6, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +104.60% | May 1, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +114.83% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $22 | Hold | Reiterates | $22 | +12.53% | Mar 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $51 | Buy | Maintains | $40 → $51 | +160.87% | Feb 13, 2025 |
Financial Forecast
Revenue This Year
49.50M
from 91.28M
Decreased by -45.77%
Revenue Next Year
71.62M
from 49.50M
Increased by 44.69%
EPS This Year
-5.29
from -5.12
EPS Next Year
-5.07
from -5.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 149.7M | 207.9M | 146.6M | ||
| Avg | 49.5M | 71.6M | 73.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.0% | 320.0% | 104.7% | ||
| Avg | -45.8% | 44.7% | 3.2% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.09 | -1.37 | -1.76 | ||
| Avg | -5.29 | -5.07 | -5.67 | ||
| Low | -6.53 | -6.79 | -10.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.